|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Kansas Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing KansasLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Sekisui XenoTech, LLC
| | | Phone: | (877) 588-7530 | Fax: | (913) 227-7100 | Year Established: | 1995 | Main Contact: | Jason Neat, COO | | Other Contacts: | David Buckley, Ph.D., CSO Joe Saitta, CFO Yasuhisa Adachi, CEO
| | Company Description | Sekisui XenoTech was formed to manufacture products and to provide services to guide the discovery and development of drugs and other consumable products, such as food addictives, fragrances, and cosmetics. XenoTech specializes in the development and application of in vitro techniques for examining the metabolism of drugs and other chemicals for pharma-ceutical firms, chemical companies, academic institutions, and regulatory agencies, such as the United States Food and Drug Administration (FDA) and the Environmental Protection Agency (EPA). XenoTech’s products and services are designed to provide pre-clinical safety information of the type recommended by the FDA to predict inter-individual variability in drug safety and efficacy, and to predict or explain adverse drug-drug interactions. | |
|
|
|
|
|